Economy

Clovis Oncology's (CLVS) "Neutral" Rating Reiterated at Piper Jaffray Cos

With 4.85M avg volume, 4 days are for Dowdupont Incorporated (NYSE:DWDP)'s short sellers to cover DWDP's short positions. The stock decreased 1.18% or $0.85 on November 3, reaching $71.16. The shares were sold at an average price of $69.50, for a total value of $208,500.00. Toll Brothers Inc (NYSE:TOL) was reduced too. It has underperformed by 16.70% the S&P500. SunTrust Banks Inc. started coverage on Clovis Oncology in a research report on Friday, August 5th. Springbok Capital Management Llc acquired 16,205 shares as Clovis Oncology Inc (CLVS)'s stock declined 20.61%. Clovis Oncology Inc now has $3.57 billion valuation. The stock increased 3.57% or $0.23 on November 3, reaching $6.67. About 877,317 shares traded. Clovis Oncology Inc (NASDAQ:CLVS) has risen 282.71% since November 4, 2016 and is uptrending. It has outperformed by 266.01% the S&P500. DowDuPont had 4 analyst reports since September 8, 2017 according to SRatingsIntel.

More recent Clovis Oncology Inc (NASDAQ:CLVS) news were published by: Businesswire.com which released: "Clovis Oncology Submits Supplemental New Drug Application for Rucaparib as ..." on October 09, 2017. RBC Capital Markets has "Top Pick" rating and $80 target. J.P. Morgan maintained the stock with "Buy" rating in Thursday, June 1 report. Cowen & Co has "Outperform" rating and $80 target. Finally, Vetr upgraded Clovis Oncology from a hold rating to a buy rating and set a $87.50 target price for the company in a report on Wednesday, July 19th. Geode Capital Management Llc who had been investing in Sprint Corp for a number of months, seems to be less bullish one the $26.68 billion market cap company. I. du Pont de Nemours and Company. It now has negative earnings. The Company's product candidates include Rociletinib, Rubraca (Rucaparib) and Lucitanib.

After the recent decrease, investors may also look to see if the stock has entered oversold territory and could possibly ripe for a reversal. The biopharmaceutical company reported ($2.07) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($2.13) by $0.06.

Large investors have recently bought and sold shares of the stock. CIBC World Markets Inc. raised its stake in Clovis Oncology by 7.8% in the first quarter. Opus Point Prns Management Ltd Com reported 1.29% stake. Prelude Limited holds 17,736 shares or 0.16% of its portfolio. Price T Rowe Md holds 2.03M shares. Gabelli Funds Ltd Liability Co reported 8,800 shares or 0% of all its holdings. Cambridge Invest Rech Advsrs Inc holds 21,976 shares or 0% of its portfolio. Canada Pension Plan Investment Board has 46,300 shares. Boothbay Fund Mgmt Ltd invested 0.05% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS). Eagle Asset, a Florida-based fund reported 621,111 shares. Samlyn Capital Ltd holds 567,700 shares or 1.3% of its portfolio. The Illinois-based Arete Wealth Advisors Llc has invested 0.25% in the stock. Moreover, Aviance Capital Partners Llc has 0.37% invested in the company for 85,703 shares. Personal Cap Advsrs Corp accumulated 493,324 shares.

Since May 15, 2017, it had 0 insider buys, and 2 selling transactions for $327,630 activity.

In related news, insider Gillian C. Ivers-Read sold 3,000 shares of the stock in a transaction dated Monday, October 16th.

Columbus Circle Investors decreased Zions Bancorporation (NASDAQ:ZION) stake by 126,077 shares to 740,465 valued at $32.51M in 2017Q2. Alliancebernstein Lp reported 0.07% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS). Therefore 63% are positive. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The firm earned "Hold" rating on Monday, May 9 by WallachBeth Capital. The rating was maintained by SunTrust with "Buy" on Friday, September 23. The Wyoming-based Cypress Capital Mngmt Limited Liability Company (Wy) has invested 0% in Clovis Oncology Inc (NASDAQ:CLVS). Stifel Nicolaus has "Buy" rating and $86 target. On Monday, January 23 the stock rating was maintained by Stifel Nicolaus with "Buy". The rating was upgraded by Credit Suisse to "Outperform" on Wednesday, September 21. JPMorgan Chase & Co. reiterated a hold rating and set a $13.00 target price on shares of Clovis Oncology in a research report on Tuesday, August 9th. The firm earned "Overweight" rating on Wednesday, May 17 by JP Morgan.



Like this

Latest


05 November 2017
Beyoncé and Donald Glover to Star in 'The Lion King' Remake
Some cast members had been previously announced for the film, including Donald Glover as Simba and James Earl Jones as Mufasa. It is scheduled for release in July 2019 and will be directed by Jon Favreau, who also led The Jungle Book reboot.

05 November 2017
Alec Baldwin's wife Hilaria Baldwin pregnant with their fourth child
Hilaria also revealed that she plans to announce the gender of the new baby to her family with a "special cake" on Saturday. And the baby news shouldn't come as a surprise as Hilaria previously revealed she would love to have another child.

05 November 2017
Florida State fraternity suspended after student's death at party
Edmunds depicted Coffey as a secondary school competitor and junior ROTC part with an ever-introduce bless his face. The two used to hang out with friends at the pier in Deerfield Beach when they were younger, he said.

05 November 2017
Wet, Windy Storm To Hit Northern California Over Weekend
A light snow fell overnight Thursday in the Donner Summit area and other upper elevations of the northern Sierra Nevada . Two storm systems will be moving through Northern California over the weekend, bringing rain and snow to the region.

04 November 2017
Vontae Davis stays home as Indianapolis heads to Houston
The Colts secondary is a thin unit as rookie cornerback Quincy Wilson was ruled out on Friday due to a nagging knee injury. Team officials announced Saturday that Davis did not make the trip because of a non-injury-related issue.

04 November 2017
Intl Fcstone Inc. Invests $500000 in Martin Marietta Materials, Inc
It turned negative, as 39 investors sold MLM shares while 161 reduced holdings. 54 funds opened positions while 141 raised stakes. On average, analysts expect that Martin Marietta Materials Inc. will post $7.14 earnings per share for the current year.

04 November 2017
QB switch proves futile as Florida gets demolished by Missouri
MISSOURI: Lock, a junior, moved past Brad Smith into second place on Missouri's career touchdown passes list. It has not been a great day for the Gators in their first game under interim head coach Randy Shannon .

04 November 2017
Chris Pratt Returns to Instagram After Split from Anna Faris
Now, the parents "amicably co-parent a human" together, according to the foreword of Anna Faris' new memoir "Unqualified". Pratt's Friday night Instagram shows just how much this dad loves his little guy.

04 November 2017
Doctor claims advances in womb transplants mean men 'could get pregnant tomorrow'
Procuring a uterus would be necessary - either from a living donor or from a brain-dead donor - a complicated, ten-hour operation. One of the most respected in the world of human reproduction, President of the American Association of reproductive medicine Dr.

04 November 2017
Rams vs. Giants injury report: Cody Davis, Olivier Vernon still sidelined
Fluker to play their best game of the season in order for the offense to function and for Eli Manning to stay on his feet. Richburg has been out since October 1 with the issue and will now be sidelined for the rest of the season.



Recommended